Literature DB >> 9604998

Characterization of two new permanent glioma cell lines 8-MG-BA and 42-MG-BA.

A Perzelová1, I Máciková, P Mráz, I Bízik, J Steno.   

Abstract

The establishment and characterization of two permanent glioma cell lines (8-MG-BA and 42-MG-BA) are described. Both cell lines were derived from the human glioblastoma multiforme. Analyzed cells were within the passage 200 to 220. The cells in both cultures showed similar morphology. In majority they consisted from flat polygonal cells. Growth kinetic studies demonstrated a population doubling time of 20 to 24 h in cell line 8-MG-BA and 48 to 54 h in cell line 42-MG-BA. The cell lines showed different hyperdiploid karyotypes. The immunofluorescence staining was performed for glial fibrillary acidic protein (GFAP) and vimentin. In the culture 8-MG-BA only a small amount of cells showed the GFAP-positive staining. At confluent 42-MG-BA culture the GFAP-positive cells reached 50 to 70% of all cells. Vimentin was found in all glioma cells in both cultures.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9604998

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  10 in total

1.  Establishment and characterization of nine human brain tumor cell lines.

Authors:  K H Shin; G Choe; Y J Park; J H Jang; H W Jung; J G Park
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001 Nov-Dec       Impact factor: 2.416

2.  Comparative evaluation of preclinical in vivo models for the assessment of replicating retroviral vectors for the treatment of glioblastoma.

Authors:  Juraj Hlavaty; Gerrit Jandl; Melissa Liszt; Helga Petznek; Marielle König-Schuster; Jenny Sedlak; Monika Egerbacher; Jakob Weissenberger; Brian Salmons; Walter H Günzburg; Matthias Renner
Journal:  J Neurooncol       Date:  2010-07-11       Impact factor: 4.130

3.  Signaling switch of the urotensin II vasosactive peptide GPCR: prototypic chemotaxic mechanism in glioma.

Authors:  C Lecointre; L Desrues; J E Joubert; N Perzo; P-O Guichet; V Le Joncour; C Brulé; M Chabbert; R Leduc; L Prézeau; A Laquerrière; F Proust; P Gandolfo; F Morin; H Castel
Journal:  Oncogene       Date:  2015-01-19       Impact factor: 9.867

4.  Establishment and partial characterization of a continuous human malignant glioma cell line: NG97.

Authors:  M C Grippo; P F Penteado; E F Carelli; M A Cruz-Höfling; L Verinaud
Journal:  Cell Mol Neurobiol       Date:  2001-08       Impact factor: 5.046

5.  Germline copy number variation of genes involved in chromatin remodelling in families suggestive of Li-Fraumeni syndrome with brain tumours.

Authors:  Juliette Aury-Landas; Gaëlle Bougeard; Hélène Castel; Hector Hernandez-Vargas; Aurélie Drouet; Jean-Baptiste Latouche; Marie-Thérèse Schouft; Claude Férec; Dominique Leroux; Christine Lasset; Isabelle Coupier; Olivier Caron; Zdenko Herceg; Thierry Frebourg; Jean-Michel Flaman
Journal:  Eur J Hum Genet       Date:  2013-04-24       Impact factor: 4.246

6.  Multidrug resistance-associated protein MRP1 expression in human gliomas: chemosensitization to vincristine and etoposide by indomethacin in human glioma cell lines overexpressing MRP1.

Authors:  B Benyahia; S Huguet; X Declèves; K Mokhtari; E Crinière; J F Bernaudin; J M Scherrmann; J Y Delattre
Journal:  J Neurooncol       Date:  2004-01       Impact factor: 4.130

7.  Contribution of gap junctional communication between tumor cells and astroglia to the invasion of the brain parenchyma by human glioblastomas.

Authors:  Roxane Oliveira; Christo Christov; Jean Sébastien Guillamo; Sophie de Boüard; Stéphane Palfi; Laurent Venance; Marcienne Tardy; Marc Peschanski
Journal:  BMC Cell Biol       Date:  2005-02-16       Impact factor: 4.241

8.  Correction of PTEN mutations in glioblastoma cell lines via AAV-mediated gene editing.

Authors:  Victoria K Hill; Jung-Sik Kim; C David James; Todd Waldman
Journal:  PLoS One       Date:  2017-05-02       Impact factor: 3.240

9.  Hypoxia upregulates expression of human endosialin gene via hypoxia-inducible factor 2.

Authors:  A Ohradanova; K Gradin; M Barathova; M Zatovicova; T Holotnakova; J Kopacek; S Parkkila; L Poellinger; S Pastorekova; J Pastorek
Journal:  Br J Cancer       Date:  2008-09-23       Impact factor: 7.640

10.  Alterations in Cell Motility, Proliferation, and Metabolism in Novel Models of Acquired Temozolomide Resistant Glioblastoma.

Authors:  D M Tiek; J D Rone; G T Graham; E L Pannkuk; B R Haddad; R B Riggins
Journal:  Sci Rep       Date:  2018-05-08       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.